Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

BACKGROUND AND PURPOSE: In randomized trials, atrial fibrillation (AF) patients receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, give...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Alonso, Alvaro, Bengtson, Lindsay, MacLehose, Richard, Lutsey, Pamela L., Chen, Lin Yee, Lakshminarayan, Kamakshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116615/
https://ncbi.nlm.nih.gov/pubmed/24994722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller